Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.

Molecules · 2015 · PMC6331818 · PMID 26556320

Europe PMC DOI

hedged sentence

0.0513

closest p · 1.0× alpha

0.0513

boldest claim

The sentences

a strong trendp = 0.0513so close (0.05 < p ≤ 0.1)

In contrast, there was a strong trend towards an improved OS in the cohort treated with the combination of Pol(Star)-DOX and rituximab when compared with the RTX-Pol-DOX conjugate ( p = 0.0513).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.